lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

3 rows where filing_uuid = "3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: government_entities, received_date (date)

issue_code 3

filing_year 1

filing_period 1

id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3059855 MARSHALL & POPP, LLC 3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c Q3 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2023 third_quarter PHA Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act, S.1339 - Pharmacy Benefit Manager Reform Act, H.R. 2679, the PBM Accountability Act, H.R.4822 - Health Care Price Transparency Act. Issues related to the 340B program, including H.R. 3290, to ensure transparency and oversight of the 340B drug discount program. Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-19T09:48:22-04:00
3059856 MARSHALL & POPP, LLC 3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c Q3 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2023 third_quarter CPT Issues related to intellectual property and patent reform, including: S.150, Affordable Prescriptions for Patients Act; S.79, Interagency Patent Coordination and Improvement Act; S.113, Prescription Pricing for the People Act; S.142, Preserve Access to Affordable Generics and Biosimilars Act; and S.148, Stop STALLING Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-19T09:48:22-04:00
3059857 MARSHALL & POPP, LLC 3cefa065-7ccb-4d4b-9ca0-e8108ea2e77c Q3 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2023 third_quarter TRD Issues related to waiving intellectual property protections for COVID-19 vaccines under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). SENATE 60000   0 0 2023-10-19T09:48:22-04:00

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);